Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shipurui is a pioneering Chinese biotechnology company specializing in the large-scale cultivation and processing of Spirulina. Established in 1993, the company operates significant production facilities at Chenghai Lake in Yunnan, one of the few natural habitats for Spirulina globally. Its product portfolio includes high-quality Spirulina powder, tablets, and specialized extracts like phycocyanin used in health supplements and functional foods. Shipurui is recognized for its integrated approach, combining research, development, and industrial-scale manufacturing to serve both domestic and international markets. The company maintains rigorous quality standards, including GMP certification, to ensure the purity and potency of its microalgae-derived products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Province Shipurui Biology Engineering.